Volume 1 Issue 1 - 2014
Looking Ahead to 2015--“The Decades of the Brain”
Theresa D Robinson*
Medical Device Head Hunter, United States of America
*Corresponding Author: Theresa D Robinson, Medical Device Head Hunter, 125 Washington St., Unit #7, Foxboro, MA 02035, United States of America.
Received: November 26, 2014; Published: December 24, 2014
Citation: Theresa D Robinson. “Looking Ahead to 2015--“The Decades of the Brain”. EC Neurology 1.1 (2014): 2-3.
Brain monitoring in 2015 seems very exciting, not because of the multinationals but rather as a result of the push and pull effect of the small start-up companies that are looking outside accepted paradigms to bring to the hospital scene new and innovative devices. While the large traded companies are adding small updates and more "bells and whistles" not really needed in the NICU and OR, foreign startups like Ornim from Israel are bringing easy to sue and noninvasive equipment which is starting to change the face of hospital practice.
Keywords: Ornim; Massimo, Casmed; Noninvasive monitoring; c-FLOW; Cerebral Monitoring; Decade of the Brain; Neuro Critical Care Society (NCCS); American Society of Anesthesiology (ASA); Cerebral Brain Flow Monitor; Gary Sagiv; Israel Schreiber; Israel
Where is the medical device technology market going in 2015? It’s an especially challenging question in the post-Obama healthcare world. While it seemed that the med tech world was gearing up for the “Obama Brain Initiative”, with a few exceptions, there has been nothing new. The Masimo Root Patient Monitoring System or the Casmed Foresight Elite Absolute Cerebral Oximeter are more of the same with little actual improvement.
The leading multi-national companies have not brought anything new to market recently. International shows such as the Neuro Critical Care Society (NCCS) and the American Society of Anesthesiology (ASA) seemed to have no breakthrough potentials even for the future from the majors.
The smaller companies are the ones bringing innovative products to the field. Neuro-interventionists and anesthesiologists are pointing to the Israeli start-up, Ornim, Inc. (, as the next major innovator in cerebral technology.
Based in Foxboro, Mass., with research and development facilities in Kfar Saba, Israel, Ornim is the first company to move away from the standard paradigm of cerebral oximetry to monitor blood flow in the brain. The device shines safe, near infrared laser light combined with pulses of ultrasound to create a Doppler-like effect that reveals blood flowing through deep tissue.
While there are other technologies that measure cerebral blood flow, none of them have the distinction of being non-invasive and continuous to provide real-time monitoring. As such, the c-FLOW Cerebral Brain Flow Monitor ( was the most innovative product at both the NCS and ASA conferences, touted by some of the nation’s leading physicians and technologists.
Lead by chief executive officer Israel Schreiber, a veteran of ITGI Medical and Itamar Medical Ltd., Ornim is investing heavily in the U.S. market after being invited by Massachusetts Gov. Deval Patrick to open facilities in the state.
The company is funded by OrbiMed Healthcare Fund, GE Healthymagination Fund, Agate Medical Investments LP and other leading venture capital funds. As the company is not publicly traded, no sales figures are available. Nonetheless, reputable figures in the industry have pointed to the deployment of the c-FLOW in some of the top 50 hospitals in the U.S. as a sign of continuing success.
Gary Sagiv, Ornim vice president of global marketing and sales, formerly of ITGI and Itamar Medical as well, said in a phone conversation that the strategy of the company was to take blood pressure management from “guessing” to “knowing” with the use of UTLight technology the company offers. “We are able to monitor a wide range of medical complications and issues in diverse clinical settings, including stroke, subarachnoid hemorrhage, bypass, shoulder surgery, CPR and more”.
“I am most excited by the ability of the c-FLOW to assist in IV-TPA during stroke therapy”, said Sagiv. “For the first time the physician has the ability to know exactly if and when the clot dissolves. The physician can then tailor the therapy to the specific need”.
Individualized medicine is the name of the game today and Ornim seems to be leading the pack. “By using our device, early detection of difficulties that can occur during surgery or post-op can be reduced, decreasing complication rates and saving patient lives”.
Sagiv noted that in an article in the New England Journal of Medicine, Dr. Wesley Ely found that ICU-related brain injury could be prevented if the duration of delirium in the ICU is shortened. “That is our aim at Ornim – to reduce the patient’s stay in the ICU and decrease future cognitive problems. At the same time, this should reduce health costs through shorter length of stay”. “With our breakthrough technology, the hospital’s clinical teams are able-for the first time-to have an immediate indication of the state of perfusion of the patient at the bedside”.
Ornim’s “out of the box” approach to medical procedures has been their hallmark. As such, the company is in synch with the times. This course of action seems to be the signature of both Schreiber and Sagiv whose track record of introducing innovative technologies has been most successful over the years (Itamar Medical is a fine example).
Individualized medicine and non-invasive technologies are some of the hottest topics being discussed today-with good reason. The recent medical examiner’s report on Joan Rivers’ death said that the late actress died from anoxic encephalopathy due to hypoxic arrest- a deprivation of oxygen that lead to brain damage.
As such, the question for her-and for so many others-becomes “Could the use of the c-FLOW have saved her life?” I know, that if I had to go into the hospital today, I would demand the use of this c-FLOW monitor!
These small companies with relatively limited resources are to bring the change to this field.
Copyright: © 2014 Theresa D Robinson. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

December Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the December issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 20, 2021.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to